Effects of Sterile Kinesio Tape on Anterior Cruciate Ligament Reconstruction

Sponsor
Baskent University (Other)
Overall Status
Completed
CT.gov ID
NCT04873921
Collaborator
(none)
56
1
2
2.5
22.7

Study Details

Study Description

Brief Summary

Anterior cruciate ligament reconstruction (ACLR) is a surgical tissue graft replacement of the anterior cruciate ligament, located in the knee, to restore its function after an injury. ACLR is used as the gold standard in coping with pain, deformity, and instability for the patients. The most important factors affecting the success of both surgery and postoperative rehabilitation programs are edema, joint movement limitation and pain around the knee in the early postoperative period. If these parameters are managed well in the postoperative period, the quality of life of the patient increases much earlier. In this respect, kinesio taping treatment, which is practical, comfortable, and safe for the patient, is one of the complementary treatment modalities with positive clinical results. No researchers have studied the effects of Sterile Kinesio Tape applied during ACL reconstruction on edema, pain and range of motion in immediate care postoperatively. The purpose of our study İS to assess effects of Sterile Kinesio Tape application on postoperative edema, pain and range of motion after ACLR within 72 hours. Thirty-seven patients who have undergone ACLR will be recruited to our study. Patients will be randomized into 2 groups; Group 1: Sterile Kinesio tape application, Group 2: Control group. All patients will be assessed for pain intensity (with Visual Analog Scale-VAS), edema (with tape measurement) and range of motion (with goniometric measurement-knee flexion/extension). Assessments will be done every day for 3 days (a total of 3 measurements). Group 1 will receive Sterile Kinesio Taping application within 72 hours applied with Sterile Web Cut Kinesio Tape without tension additional to standard during ACLR postoperative care. Group 2 will receive only standard postoperative care.

Condition or Disease Intervention/Treatment Phase
  • Other: sterile kinesio taping
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients are randomized into 2 groups; Group 1: Sterile Kinesio tape application (n=28), Group 2: Control group (n=28). Group 1 will receive Sterile Kinesio Taping application within 72 hours applied with Sterile Web Cut Kinesio Tape without tension additional to standard postoperative care. Group 2 will receive only standard postoperative care.Patients are randomized into 2 groups; Group 1: Sterile Kinesio tape application (n=28), Group 2: Control group (n=28). Group 1 will receive Sterile Kinesio Taping application within 72 hours applied with Sterile Web Cut Kinesio Tape without tension additional to standard postoperative care. Group 2 will receive only standard postoperative care.
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Group 1 and 2 will be assessed and treated by two different experienced physiotherapists for each group.
Primary Purpose:
Treatment
Official Title:
Immediate Effects of Sterile Kinesio Tape Applied During Anterior Cruciate Ligament Reconstruction on Edema, Pain and Range of Motion
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
May 15, 2021
Actual Study Completion Date :
May 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1: Sterile Kinesio tape application

Sterile Kinesio Taping application will be applied with Sterile Web Cut Kinesio Tape (Sterile Kinesio Tex Tape, Alberquerque, USA) without tension.

Other: sterile kinesio taping
Application area will be cleaned and dried prior to application to increase the adhesiveness of the tape and application will be done by an experienced physiotherapist during ACLR surgery.
Other Names:
  • taping
  • No Intervention: Group 2: Control group

    Group 2 will not receive any taping

    Outcome Measures

    Primary Outcome Measures

    1. Pain Intensity [3 days]

      Pain intensity will be assessed (every day for 3 days) with Visual Analog Scale (VAS). VAS is a 10-cm line with no marks along it, anchored with the words "no pain" on one hand, and "the most severe pain" on the other. Patients will be simply instructed to place a mark along the line at a level representing the intensity of their pain during activity

    2. Edema Assessment [3 days]

      Edema will be assessed (every day for 3 days) with circumferential measurements in centimeters using basic tape measurement for ACLR knees at 5 levels: incision level, upper part of incision (5 cm above and 10 cm above) and lower part of incision (5 cm below and 10 cm below)

    3. Range of motion measurement [3 days]

      Range of motion measurement will be done (every day for 3 days) with universal goniometry for knee flexion and extension. Knee flexion and extension movements will be measured in the supine position for both knees. The measurements will be recorded in degrees

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • patients who underwent anterior cruciate ligament reconstruction
    Exclusion Criteria:
    • with soft tissue or bone problems affecting the hip or ankle

    • who any neurologic problems,

    • who had any systematic rheumatic problems,

    • had scoliosis,

    • who had undergone orthopedic surgery before,

    • who were obese (BMI> 30 kg/m2)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Baskent University Ankara Turkey 06790

    Sponsors and Collaborators

    • Baskent University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Nihan Ozunlu Pekyavas, Associated Proffesor, Baskent University
    ClinicalTrials.gov Identifier:
    NCT04873921
    Other Study ID Numbers:
    • KA 21/133
    First Posted:
    May 5, 2021
    Last Update Posted:
    Jun 22, 2021
    Last Verified:
    Jun 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Nihan Ozunlu Pekyavas, Associated Proffesor, Baskent University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2021